Ayako Suzuki

Active 1981–2025

144
Papers
18,940
Citations
65
h-index
128
i10-index

Citations

Citations per year for Ayako Suzuki1983: 2 citations1984: 5 citations1985: 4 citations1986: 2 citations1987: 4 citations1988: 3 citations1989: 4 citations1990: 6 citations1991: 3 citations1992: 1 citations1993: 7 citations1994: 3 citations1995: 6 citations1996: 13 citations1997: 15 citations1998: 11 citations1999: 10 citations2000: 12 citations2001: 12 citations2002: 14 citations2003: 11 citations2004: 6 citations2005: 15 citations2006: 30 citations2007: 34 citations2008: 44 citations2009: 43 citations2010: 62 citations2011: 60 citations2012: 63 citations2013: 79 citations2014: 107 citations2015: 126 citations2016: 141 citations2017: 131 citations2018: 108 citations2019: 417 citations2020: 741 citations2021: 867 citations2022: 828 citations2023: 652 citations2024: 1,196 citations2025: 713 citations2026: 18 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,988 citing papers, 20.7% of this breakdownChina: 1,303 citing papers, 13.5% of this breakdownUnited Kingdom: 618 citing papers, 6.4% of this breakdownItaly: 479 citing papers, 5% of this breakdownJapan: 442 citing papers, 4.6% of this breakdownGermany: 407 citing papers, 4.2% of this breakdownSpain: 310 citing papers, 3.2% of this breakdownFrance: 272 citing papers, 2.8% of this breakdownCanada: 270 citing papers, 2.8% of this breakdownAustralia: 249 citing papers, 2.6% of this breakdownSouth Korea: 223 citing papers, 2.3% of this breakdownIndia: 209 citing papers, 2.2% of this breakdown
0%20.7%Other 29.7%

Fields

  • Medicine55.3%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Pharmacology, Toxicology and Pharmaceutics5.9%
  • Nursing4%
  • Immunology and Microbiology3.1%
  • Mathematics2.9%
  • Other12%

Topics

  • Liver Disease Diagnosis and Treatment12.2%
  • Diet, Metabolism, and Disease4.1%
  • Drug-Induced Hepatotoxicity and Protection2.6%
  • Liver Disease and Transplantation2.5%
  • Alcohol Consumption and Health Effects1.8%
  • Liver physiology and pathology1.7%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Sex and gender: modifiers of health, disease, and medicine

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2020 cited by 1,989

  2. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps

    Authors: , , , , , , , - Hepatology 2019 cited by 1,052

  3. Drug-induced liver injury

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2019 cited by 801

  4. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samer Gawrieh, Niharika Samala, Raj Vuppalanchi, Danielle Carpenter, Theresa Cattoor, Janet Freebersyser, Brent A. Neuschwander‐Tetri, Pannapat Angkanaworakul, Achashman Berihun, Andrew Buysse, Theresa Dorrian, Breanna Gulati, Kris V. Kowdley, Kevin Liu, S Misić, Adam Sohal, J. Vuong, Veeral Ajmera, Cynthia Behling, Rohit Loomba, Egbert Madamba, Michael S. Middleton, Lisa Richards, Seema Singh, Claude B. Sirlin, Ryan M. Gill, Bilal Hameed, Remilekun Awe, Daisy Rios Olvera, Norah A. Terrault, Liyun Yuan, Matthew M. Yeh, Somaya Albhaisi, Amon Asgharpour, Sherry Boyett, Melissa J. Contos, Velimir A. Luketic, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, David E. Kleiner, Peggy Adamo, Patricia Belt, Jeanne M. Clark, Jennifer DeSanto, Jill Meinert, Laura Miriel, Emily Mitchell, Carrie Shade, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta, Annette Wagoner, Laura A. Wilson, Tinsay A. Woreta, Katherine P. Yates, Rohit Loomba - Gastroenterology 2023 cited by 167

  5. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans

    Authors: , , , , , - Drug Discovery Today 2016 cited by 393

  6. Single-cell sequencing techniques from individual to multiomics analyses

    Authors: , , , , , - Experimental & Molecular Medicine 2020 cited by 269

  7. Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masaki Mori, Takeshi Iwasaki, Yoshinao Oda, Tatsuhiro Shibata, Yutaka Suzuki, Teppei Shimamura, Koshi Mimori - Cell Reports 2023 cited by 132

  8. AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

    Authors: , , , , , , - Hepatology 2022 cited by 240

  9. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis

    Authors: , , , , , , - Hepatology 2013 cited by 375

  10. Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 130

  11. Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , - Gastroenterology 2013 cited by 394

  12. Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , - Hepatology 2010 cited by 762

  13. Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression

    Authors: , , , , , , , , , , , - Nature Communications 2022 cited by 88

  14. A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study

    Authors: , , , , , , , , - Contemporary Clinical Trials 2023 cited by 44

  15. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2024 cited by 33

  16. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , - Hepatology 2016 cited by 195

  17. No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial

    Authors: , , , , - Gastroenterology 2014 cited by 308

  18. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research

    Authors: , - Journal of Clinical Medicine 2020 cited by 129

  19. Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression

    Authors: , , , , , , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2019 cited by 101

  20. Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , - Hepatology 2013 cited by 320

  21. Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 104

  22. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer

    Authors: , , , , , , , , , , , - Genome biology 2021 cited by 110

  23. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis

    Authors: , , , , , , , , , , , , - Nature Communications 2022 cited by 81

  24. Drug-induced liver injury: Interactions between drug properties and host factors

    Authors: , , , , - Journal of Hepatology 2015 cited by 416